Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
暂无分享,去创建一个
T. Visakorpi | O. Kallioniemi | A. Syvänen | J. Isola | A. Kallioniemi | R. Karhu | E. Hyytinen | T. Tammela | T. Tammela | Ann-Christine Syvà | Jorma J-Isola | Offi-P. Kalliomemi
[1] P. Malone,et al. Prostate , 1995 .
[2] J Piper,et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.
[3] E. Bergstralh,et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. , 1994, Cancer research.
[4] M R Speicher,et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. , 1994, Cancer research.
[5] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[6] S. Brewster,et al. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. , 1994, The Journal of urology.
[7] D. Morton,et al. Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. , 1994, British journal of urology.
[8] I. Petersen,et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. , 1994, Cancer research.
[9] J Piper,et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Croce,et al. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. , 1994, Cancer research.
[11] P. Troncoso,et al. Trisomy 7: A potential cytogenetic marker of human prostate cancer progression , 1994, Genes, chromosomes & cancer.
[12] A. Jauch,et al. Copyright ©) American Society for Investigative Pathology Comparative Genomic Hybridization of Human Malignant Gliomas Reveals Multiple Amplification Sites and Nonrandom Chromosomal Gains and Losses , 2022 .
[13] P. Walsh,et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.
[14] J. Ragoussis,et al. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. , 1993, British Journal of Cancer.
[15] T. Visakorpi,et al. New prognostic factors in prostatic carcinoma. , 1993, European urology.
[16] M. Stearns,et al. Prostate cancer: therapeutic, diagnostic, and basic studies. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[17] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[18] W. Cavenee,et al. Accumulation of genetic defects during astrocytoma progression , 1992, Cancer.
[19] A. Sandberg. Chromosomal abnormalities and related events in prostate cancer. , 1992, Human pathology.
[20] V. P. Collins,et al. Allelotyping of human prostatic adenocarcinoma. , 1991, Genomics.
[21] J. Trent,et al. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. , 1991, Cancer research.
[22] P L Pearson,et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. , 1991, Oncogene.
[23] U. Bergerheim,et al. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma , 1991, Genes, chromosomes & cancer.
[24] R. deVere White,et al. Activated ras alleles in human carcinoma of the prostate are rare. , 1991, Cancer research.
[25] W. Isaacs,et al. ras gene mutations in human prostate cancer. , 1990, Cancer research.
[26] J M Trent,et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. , 1990, Science.
[27] J D Siegal,et al. Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers , 1988, The Prostate.